REGN34:BVMF
Regeneron Pharmaceuticals Inc BDR
R$67.48
arrow_upward
+0.63%(+0.42) 1D
Oct 21, 4:56:00 PM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN34...
Open
R$67.13
High
R$67.48
Low
R$67.13
Mkt. cap
82.95B
Avg. vol.
686.00
Volume
0.00
52-wk high
R$73.13
52-wk low
R$49.91
Shares outstanding
101.14M
No. of employees
15K
Open
R$67.13
High
R$67.48
Low
R$67.13
Mkt. cap
82.95B
Avg. vol.
686.00
Volume
0.00
52-wk high
R$73.13
52-wk low
R$49.91
Shares outstanding
101.14M
No. of employees
15K
News stories
From web sources and news partners
Trefis
·
3 hours ago
Are You Overpaying For Regeneron Stock Versus Its Rivals?
AD HOC NEWS
·
8 hours ago
Regeneron stock: Piper Sandler raises target to USD 865.00
MarketBeat
·
8 hours ago
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Gets Price Target Bump from TD Cowen
AD HOC NEWS
·
14 hours ago
Regeneron recommends longer Libtayo dosing. Regeneron stock is valued at USD 83.1 billion
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc BDR
CEOLeonard Schleifer
Employees15.3K
Founded1988
HeadquartersTarrytown, New York, United States
SectorBiotechnology
Websiteregeneron.com